Marine Algae: Bioactive Compounds & Pharmaceutical Potential
Explore the science of marine algae, bioactive molecules like fucoidan, and extraction methods for pharmaceuticals, nutraceuticals, and functional foods.
SCIENTIFIC STUDY
Marine Algae
as a Source of
Bioactive Compounds
Exploring the Ocean's Pharmaceutical Potential
Research Presentation · 2026
CONTENTS
What We'll
Cover
01
Introduction
Marine algae overview & classification
02
Types of Algae
Green, brown, red & microalgae
03
Bioactive Compounds
Key molecules & chemical classes
04
Biological Activities
Antioxidant, antimicrobial & more
05
Extraction Methods
MAE, UAE & supercritical techniques
06
Applications & Future
Pharma, nutraceuticals & outlook
01 — INTRODUCTION
The Ocean's Hidden Treasure
Marine algae are among Earth's most productive organisms, covering 71% of our planet. They represent a largely untapped reservoir of bioactive molecules with immense pharmaceutical potential.
~30,000
Species of algae known globally
>1,000
Bioactive compounds identified
$12B+
Global seaweed market value
02 — TYPES OF ALGAE
Classification of Marine Algae
Green Algae
(Chlorophyta)
Rich in polysaccharides and pigments
Chlorophylls, Ulvan, Carotenoids
Ulva lactuca, Caulerpa sp.
Brown Algae
(Phaeophyta)
Most bioactive, highest fucoidan content
Fucoidan, Alginic acid, Phlorotannins, Laminarin
Laminaria, Sargassum, Fucus
Red Algae
(Rhodophyta)
Key source of gelling agents & pigments
Carrageenan, Agar, Phycoerythrin
Gracilaria, Porphyra, Chondrus
Microalgae
(Various Phyla)
Microscopic powerhouses of nutraceuticals
EPA, DHA (omega-3s), Astaxanthin, Spirulina
Spirulina, Chlorella, Haematococcus
03 — BIOACTIVE COMPOUNDS
Key Molecules & Chemical Classes
Marine algae synthesize a diverse array of secondary metabolites in response to environmental stress, predation, and competition — many of which exhibit remarkable pharmaceutical properties.
Fucoidan, carrageenan, agar; anti-inflammatory & anticoagulant
Phlorotannins; potent antioxidant & antimicrobial activity
Fucoxanthin, astaxanthin; antioxidant & anticancer properties
EPA, DHA; essential omega-3s with cardioprotective effects
Phycobiliproteins; bioactive peptides with ACE-inhibitory activity
04 — BIOLOGICAL ACTIVITIES
Pharmacological Properties
Antioxidant Activity
Algal polyphenols and carotenoids (fucoxanthin, astaxanthin) neutralize free radicals, reducing oxidative stress linked to aging and chronic disease.
Fucoxanthin, Phlorotannins
Antimicrobial Activity
Phlorotannins and halogenated compounds show broad-spectrum activity against Gram-positive and Gram-negative bacteria, fungi, and viruses.
Phlorotannins, Halogenated terpenes
Anti-inflammatory Activity
Fucoidan and sulfated polysaccharides suppress NF-κB pathways, reducing pro-inflammatory cytokine production.
Fucoidan, Laminarin
Anticoagulant Activity
Sulfated polysaccharides from red and brown algae show heparin-like anticoagulant activity, reducing thrombosis risk.
Carrageenan, Fucoidan
Anticancer Activity
Several algal compounds induce apoptosis in cancer cell lines (breast, colon, lung), with fucoidan showing tumor-suppressive properties.
Fucoidan, Fucoxanthin
Antiviral Activity
Sulfated polysaccharides interfere with viral attachment and replication, showing activity against HIV, herpes, and influenza viruses.
Carrageenan, Ulvan
05 — EXTRACTION METHODS
Isolating Bioactive Compounds
The efficiency and selectivity of extraction methods directly determine the yield and quality of bioactive compounds recovered from marine algae. Modern techniques prioritize green chemistry principles.
MAE yields ~70 mg bioactives/g biomass — outperforming conventional methods
Microwave-Assisted Extraction (MAE)
★★★★★
~70 mg/g yield, fast, energy-efficient
Ultrasound-Assisted Extraction (UAE)
★★★★☆
Cell disruption via cavitation, gentle conditions
Enzyme-Assisted Extraction (EAE)
★★★☆☆
Selective, preserves bioactivity, eco-friendly
Supercritical Fluid Extraction (SFE)
★★★★☆
CO₂ solvent, no residues, high purity
06 — APPLICATIONS
From Ocean to Industry
Pharmaceuticals
Nutraceuticals & Food
Anti-cancer drug candidates (fucoidan-based)
Anticoagulant agents (carrageenan analogs)
Anti-inflammatory therapeutics
Antiviral compounds (against HIV, HSV, influenza)
Wound-healing and tissue-repair biomaterials
Omega-3 supplements (EPA, DHA from microalgae)
Antioxidant-rich functional foods
Prebiotic dietary fiber (alginate, agar)
Natural food colorants (phycocyanin, astaxanthin)
Protein-rich health supplements (Spirulina, Chlorella)
Cosmetics
Anti-aging, UV-protection creams with algal extracts
Agriculture
Biostimulants and natural fertilizers
Biofuels
Microalgae as sustainable bioenergy feedstocks
CHALLENGES & FUTURE
Obstacles and Opportunities
Despite immense potential, several bottlenecks slow the translation of marine algal bioactive compounds from bench to market.
Scalability of extraction at industrial level
Variability in compound concentration by season/geography
Regulatory hurdles for novel marine ingredients
High purification and standardization costs
Future Directions
AI-assisted screening of algal compound libraries
Sustainable aquaculture-based algae farming
Nanotechnology-enhanced bioavailability delivery systems
Genomics & metabolomics for strain optimization
2020
Major fucoidan anti-cancer trials
2022
Microalgae omega-3 FDA approvals
2024
First algae-based antiviral clinical trials
2026
Expanded WHO interest in marine nutraceuticals
2030+
Mainstream pharmaceutical pipeline integration
CONCLUSION
Key Takeaways
Marine algae are a vast, underexplored source of bioactive molecules
Brown algae (fucoidan, phlorotannins) show the broadest bioactivity
Microwave-assisted extraction achieves the highest compound yields
Applications span pharma, nutrition, cosmetics & agriculture
Sustainable harvesting and green extraction are critical priorities
"The ocean holds the next generation of life-saving medicines."
Thank You · Research Presentation 2026
- marine-algae
- bioactive-compounds
- biotechnology
- pharmaceuticals
- nutraceuticals
- green-extraction
- fucoidan
- marine-science